We want to meet you @CES 2025
FlowBeams will attend the world’s most influential tech event on January 7-10, 2025, in the heart of Las Vegas.
We are inviting visionaries, industry leaders, and investors to join our vision for a needle-free future.
Transforming industries, one drop at a time
Our innovative microfluidics technology is reshaping healthcare, cosmetics, and beyond.
- OUR TECHNOLOGY
We use lasers and microfluidic jets to penetrate the skin with accuracy.
- PROVEN ADVANTAGES
Superior injection depth control with targeting intradermal delivery.
- Eco-Friendly
Eliminates biohazardous needle waste, reducing the 44 million needles daily used worldwide.
-
SAFETY
FIRST
No sharp components means no needle-stick risk injuries in cosmetics and healthcare.
Experience The Needle Free Future
Step into our interactive booth and learn about the endless possibilities that FlowBeams’ technology can offer.
Our experts will show you how our technology will revolutionize multiple industries.
Don’t miss this chance to be at the forefront of a technological leap.
We're seeking partnerships across industries,
with leaders in ...
Healthcare
… to integrate our needle-free technology into personalized solutions, revolutionizing drug delivery and patient care.
Cosmetics
… to redefine cosmetic and beauty tech with precision and damage free delivery system into next-generation aesthetic treatments.
Animal health
… to provide stress-free care with needle-free solutions with compassion for animals.
Agrotech
… to enhance crops with our technology for precise delivery of nutrients and more sustainability.
Do you have other ideas?
We are open to explore business opportunities in other sectors, including biotech, materials science, and environmental.
We’re open to partnerships to leverage our needle-free technology for groundbreaking applications, from advanced manufacturing to eco-friendly waste reduction initiatives.
We would love to hear from you! Feel free to book a meeting with us!
Who's gonna be there?
- Chief Executive Officer & Co-founder
- 7 - 11 Jan
- Chief Technology Officer
- 7 - 11 Jan